Allergies News and Research

Latest Allergies News and Research

Scientists discover how a protein and enzymes interact to allow hepatitis A virus replication

The viral replication cycle is crucial for a virus to spread inside the body and cause disease. Focusing on that cycle in the hepatitis A virus (HAV), UNC School of Medicine scientists discovered that replication requires specific interactions between the human protein ZCCHC14 and a group of enzymes called TENT4 poly(A) polymerases.

4 Jul 2022

New discovery could lead to more effective treatments for asthma sufferers

New research led by Edith Cowan University has made an important discovery that could lead to more effective treatments for the world's 262 million asthma sufferers.

4 Jul 2022

HIV accelerates epigenetic aging soon after initial HIV infection

HIV has an "early and substantial" impact on aging in infected people, accelerating biological changes in the body associated with normal aging within just two to three years of infection, according to a study by UCLA researchers and colleagues.

1 Jul 2022

Stopping a pervasive bacterium that makes millions sick each year

As we head outdoors this summer, scientists are working to clip the long, flexible appendages that enable the common bacterium Campylobacter jejuni to make its way from undercooked poultry and natural waterways into our intestinal tract where it makes millions of us sick each year.

1 Jul 2022

Novel universal flu vaccine confers protection against different strains and subtypes of influenza A viruses

A new universal flu vaccine constructed with key parts of the influenza virus offers broad cross protection against different strains and subtypes of influenza A viruses in young and aged populations, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

30 Jun 2022

The risk of SARS-CoV-2 infection and disease severity in a cohort of severe asthmatics treated with biologics

Researchers assessed the risk of SARS-CoV-2 infection in asthma patients taking biologics.

29 Jun 2022

Phase 1 clinical trial of new influenza vaccine begins at NIH Clinical Center in Bethesda

A Phase 1 clinical trial of a novel influenza vaccine has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland.

28 Jun 2022

SARS-CoV-2 virus undertakes a massive takeover of the body's fat-processing system

The virus that causes COVID-19 undertakes a massive takeover of the body's fat-processing system, creating cellular storehouses of fat that empower the virus to hijack the body's molecular machinery and cause disease.

28 Jun 2022

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a low-dose, oral COVID antiviral drug that can be administered at home.

27 Jun 2022

Techniques used in weather forecasting can be repurposed to assess risk of COVID-19 exposure

Techniques used in weather forecasting can be repurposed to provide individuals with a personalized assessment of their risk of exposure to COVID-19 or other viruses, according to new research published by Caltech scientists.

23 Jun 2022

Researchers continue a national study to evaluate COVID-19 vaccination safety pre-and post-delivery

With the SARS-CoV-2 pandemic ongoing, researchers at University of California San Diego School of Medicine, in collaboration with the American Academy of Allergy Asthma and Immunology, will continue a national study to evaluate the safety of COVID-19 vaccinations during pregnancy, and monitor immune response for mother and baby following vaccinations.

23 Jun 2022

Childhood bronchitis increases the risk of lung diseases in adult life

Bronchitis in early childhood has been found to increase the risk of lung diseases in middle age according to research from the Allergy and Lung Health Unit at the University of Melbourne.

21 Jun 2022

How specific comorbidities impact severity of COVID-19

Researchers identify the association between severe COVID-19 and specific comorbidities.

20 Jun 2022

UTSW study provides a potential avenue for the development of new antivirals against influenza

A collaborative study from UT Southwestern scientists has identified a new function for a protein called TAO2 that appears to be key to inhibiting replication of the influenza virus, which sickens millions of individuals worldwide each year and kills hundreds of thousands.

20 Jun 2022

GPR183 gene a novel drug target for severe COVID-19

In a recent study posted to the bioRxiv* pre-print server, researchers provide the first preclinical evidence of the usefulness of antagonists of G-protein coupled receptor 183 (GPR183), also known as Epstein-Barr virus-induced gene 2 (EBI2), in reducing coronavirus disease 2019 (COVID-19) severity.

17 Jun 2022

UB program secures $12.8 million to improve the quality of global HIV research

The National Institutes of Health (NIH) has awarded $12.8 million to the University at Buffalo School of Pharmacy and Pharmaceutical Sciences to lead a clinical pharmacology quality assurance program for NIH-funded laboratories and research networks across the globe conducting HIV and infectious disease research.

16 Jun 2022

Oral immunotherapy for peanut allergies is highly effective when started for infants under 12 months

UBC researchers demonstrated in 2019 that pre-schoolers can safely overcome peanut allergies with a treatment called oral immunotherapy.

16 Jun 2022

Stanford researcher outlines pollution and climate change threats to children's health

Horror stories of children trapped in hot cars make headlines, but air pollution and impacts from a changing climate are more constant threats.

15 Jun 2022

Pulmonary and primary care experts aim to reduce the time to diagnose interstitial lung diseases

The American College of Chest Physicians (CHEST) and Three Lakes Foundation are announcing a steering committee of experts in the fields of pulmonary medicine and primary care medicine to lead an initiative called Bridging Specialties™: Timely Diagnosis for ILD Patients.

9 Jun 2022

Ventilation key to reducing COVID-19 spread in schools

Recently, Centres for Disease Control and Prevention (CDC) evaluated the aforementioned data on ventilation improvement strategies implemented in kindergarten through grade 12 (K–12) public schools in the United States.

8 Jun 2022

Allergies News and Research

Latest Allergies News and Research

Scientists discover how a protein and enzymes interact to allow hepatitis A virus replication

New discovery could lead to more effective treatments for asthma sufferers

HIV accelerates epigenetic aging soon after initial HIV infection

Stopping a pervasive bacterium that makes millions sick each year

Novel universal flu vaccine confers protection against different strains and subtypes of influenza A viruses

The risk of SARS-CoV-2 infection and disease severity in a cohort of severe asthmatics treated with biologics

Phase 1 clinical trial of new influenza vaccine begins at NIH Clinical Center in Bethesda

SARS-CoV-2 virus undertakes a massive takeover of the body's fat-processing system

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Techniques used in weather forecasting can be repurposed to assess risk of COVID-19 exposure

Researchers continue a national study to evaluate COVID-19 vaccination safety pre-and post-delivery

Childhood bronchitis increases the risk of lung diseases in adult life

How specific comorbidities impact severity of COVID-19

UTSW study provides a potential avenue for the development of new antivirals against influenza

GPR183 gene a novel drug target for severe COVID-19

UB program secures $12.8 million to improve the quality of global HIV research

Oral immunotherapy for peanut allergies is highly effective when started for infants under 12 months

Stanford researcher outlines pollution and climate change threats to children's health

Pulmonary and primary care experts aim to reduce the time to diagnose interstitial lung diseases

Ventilation key to reducing COVID-19 spread in schools

Costly Chemicals; The Health and Economic Impact of 'Forever Chemicals'

Crying out for new disease diagnoses

Understanding the emotions behind memories

Allergies News and Research

Latest Allergies News and Research

Costly Chemicals; The Health and Economic Impact of 'Forever Chemicals'

Crying out for new disease diagnoses

Understanding the emotions behind memories

Newsletters you may be interested in